Vera Therapeutics (VERA) Free Cash Flow (2020 - 2026)
Vera Therapeutics (VERA) posted Free Cash Flow of -$106.5 million for Q1 2026, down 51.97% on a QoQ basis from -$70.1 million in Q4 2025, and down 95.12% year-over-year from -$2.2 billion in Q1 2025.
Vera Therapeutics (VERA) Free Cash Flow (2020 - 2026) Analysis & Trends
Vera Therapeutics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$106.5 million for Q1 2026.
- Quarterly Free Cash Flow fell 95.12% year-over-year to -$106.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$293.7 million (down 87.75% YoY) and the FY2025 annual result came in at -$241.7 million, down 78.2% from the prior year.
- Free Cash Flow was -$106.5 million for Q1 2026 at Vera Therapeutics, down from -$70.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$9.0 million in Q1 2022 and bottomed at -$106.5 million in Q1 2026.
- A 5-year average of -$37.9 million and a median of -$26.3 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 236.58% — and 2023, when it grew 6.65%.
- Vera Therapeutics' Free Cash Flow stood at -$21.2 million in 2022, then dropped by 19.11% to -$25.2 million in 2023, then plunged by 58.0% to -$39.8 million in 2024, then slumped by 76.0% to -$70.1 million in 2025, then slumped by 51.97% to -$106.5 million in 2026.
- Business Quant data shows VERA's Free Cash Flow at -$106.5 million in Q1 2026, -$70.1 million in Q4 2025, and -$62.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -106.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.52 Mn |
| Mar 31, 2026 | -106.52 Mn |
| Dec 31, 2025 | -70.10 Mn |
| Dec 31, 2025 | -70.10 Mn |
| Sep 30, 2025 | -62.04 Mn |
| Sep 30, 2025 | -62.04 Mn |
| Jun 30, 2025 | -55.01 Mn |
| Jun 30, 2025 | -55.01 Mn |
| Mar 31, 2025 | -54.59 Mn |
| Mar 31, 2025 | -54.59 Mn |
| Dec 31, 2024 | -39.83 Mn |
| Dec 31, 2024 | -39.83 Mn |
| Sep 30, 2024 | -37.12 Mn |
| Sep 30, 2024 | -37.12 Mn |
| Jun 30, 2024 | -24.87 Mn |
| Jun 30, 2024 | -24.87 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Dec 31, 2023 | -25.21 Mn |
| Dec 31, 2023 | -25.21 Mn |